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ABSTRACT (Maximum 200 Words)
The p53 tumor suppressor gene mediates a pathway leading to G1 cell cycle arrest and/or apoptosis.
p53 function is frequently altered in breast cancer and other human cancers. p53 protein is kept at a low level during normal cell growth by its short half-life and is stabilized following oncogenic stimulation and DNA damage.
This research is exploring factors that contribute to the stabilization of p53 after oncogenic stimulation.
MDM2 oncoprotein binds to and targets p53 for degradation in the cytoplasm.
The tumor suppressor ARF stabilizes p53 by blocking the nuclear export of both p53 and MDM2.
In work under this award, it was shown that ARF has biological activity independent of p53.
Overexpression of ARF impedes DNA synthesis, resulting in accumulation of cells in S phase.
Hence, ARF induction induces predominantly G1 arrest if p53 is present or S-phase retardation in the absence of p53. The Principal Investigator (PI) also obtained evidence that p53 protein contains two nuclear export-ing signal sequences, one specific for MDM2 and one whose activity is independent of MDM2.
INTRODUCTION
The p53 tumor suppressor gene mediates a major tumor suppression pathway in mammalian cells that is frequently altered in human cancers (Levine, 1997; Prives, 1998; Sherr, 1998) . p 5 3 protein is kept at low level during normal cell growth by its short half-life and is stabilized following oncogenic stimulation and DNA damage. Growing evidence has identified MDM2 as a key regulator of p53 protein stability (Haupt et al., 1997; Kubbutat et al., 1997) . Blocking p53 nuclear exporting leads to p53 stabilization (Roth et al., 1998; Freeman et al., 1998) , indicating that p53 degradation occurs in the cytoplasm and suggesting p53 nuclear export as a major regulatory event in MDM2-mediated p53 degradation. The tumor suppressor ARF stabilizes p53 by blocking the nuclear export of both p53 and MDM2 Zhang and Xiong, 1999) . Human tumor-derived mutations in the ARFINK4a locus can selectively target the ARF gene and impair ARF function in blocking p53 nuclear export, underscoring the importance of nuclear export in regulating p53 stability . The mechanism governing p53 nuclear export has been under intense investigation, but remains unclear and controversial at present.
The mammalian ARF-INK4a locus uniquely encodes two cell cycle inhibitors, p16INK 4 a (Serrano et al., 1993) and ARF (Quelle et al., 1995) , by using separate promoters and alternative reading frames, that both function in tumor suppression. Mice with homozygous deletion of both p16 and ARF (Serrano et al., 1996) , or selective deletion of ARF, sparing p16 (Kamijo et al., 1997), develop spontaneous tumors at an early age. p16TNK 4 a encodes a specific inhibitor of CDK4/CDK6 and maintains the retinoblastoma protein in its growth suppressive state through inhibition of its phosphorylation(Serrano et al., 1993), while ARF binds to and inactivates MDM2, thereby stabilizing p53 (Pomerantz et al., 1998; Zhang et al., 1998; Stott et al., 1998) . MDM2 binds to and abrogates p53 function by either targeting p53 for degradation in the cytoplasm or by repressing p53's transcriptional activity in the nucleus [reviewed in (Levine, 1997; Prives, 1998) ]. ARF inhibits MDM2 at least in part by preventing MDM2-dependent nuclear export and cytoplasmic degradation of p53 Tao and Levine, 1999) , through forming ARF-MDM2-p53 ternary complex .
We showed previously that ARF forms nuclear bodies with MDM2 and p53 and blocks p53 and MDM2 nuclear export, thereby inhibiting MDM2-mediated p53 degradation (Zhang and Xiong, 1998) . Like oncogenic signals, DNA damage also activate p53, but through an ARF-independent pathway that involved p53 protein phosphorylation by several DNA damage-activated kinases. One of the major findings we made over the past year is that DNA damage pathway also causes p53 stabilization through regulating p53 nuclear export. The p53 gene mediates a major tumor suppression pathway that is frequently altered in human cancers (Levine, 1997) . p53 is inhibited during normal cell growth by MDM2, a proto-oncogene discovered by its genomic amplification on a murine double minute chromosome, through either ubiquitin-dependent p53 degradation in the cytoplasm, or repression of p53's transcriptional activity in the nucleus. p53 is activated following DNA damage through p53 phosphorylation (Prives, 1998), or in response to oncogenic insults by the activation of ARF, a tumor suppressor encoded by the alternative reading frame of the INK4a locus that is frequently altered in human cancers (Sherr, 1998) . Blocking p53 nuclear export leads to p53 stabilization and activation (Roth et al., 1998; , and ARF stabilizes p53, in part, by blocking the nuclear export of both p53 and MDM2 (Zhang and Xiong, 1998) , underscoring the importance of nuclear export in regulating p53 stability.
The N-terminal sequence in p53 is required for its nuclear export
To clarify the role of MDM2 in p53 nuclear export and discriminate between these models, we first examined the sensitivity to MDM2-mediated degradation and nuclear export of p53 harboring either L14Q/F19S or L22Q/W23S mutations in its N-terminal region. To our surprise, despite containing the intact NES in the COOH-terminal region (Stott et al. 1998 ), both p 5 3 L14Q/IF19s and p 5 3 L 2 3 s exhibited significantly decreased nuclear export activity, from 73% seen with wild type p53 to 23% and 15% with the two mutants. Thus, the COOH-terminal located NES was required, but not sufficient, for p53 nuclear export. Supporting the idea that the inhibitory effect of L22Q/W23S mutation on p53 export may be reduced or even masked by the overproduction of p53, endogenous p53L22Q/w23S protein produced by a knock-in strategy that was expressed at a lower level is more completely blocked from nuclear export and accumulates to very high levels in the nucleus, providing in vivo evidence for the disruption of p53 nuclear export by L22Q/W23S mutations.
MDM2 is not required for p53 nuclear export
Blockage of p53 nuclear export by the L14Q/F19S and L22Q/W23S mutations could be attributed to the disruption of p53-MDM2 association if MDM2 shuttled p53 out of the nucleus (Roth et al. 1998) or if MDM2 was required for p53 nuclear ubiquitination and its subsequent export (Boyd et al. 2000; Geyer et al. 2000) . Alternatively, it could be attributed to an intrinsic property of the NH 2 -terminal domain of p53. We carried out a series of heterokaryon assays to determine if p53 nuclear export was dependent on MDM2. After examining a large number of heterokaryons, we did not observe apparent differences in p53 nuclear export efficiency in the absence of HDM2 or in the presence of high levels of HDM2. To exclude the possibility that trace amounts of HDM2 in the Saos-2 cells might have traveled to p53'--MDM2' MEFs and promoted p53 export, we performed a similar heterokaryon assay in which p53-'-MDM2/ MEFs were first infected with p53-expressing adenoviruses and then fused with Saos-2 cells that had been infected with ARF-expressing adenoviruses to block MDM2 export. In these experiments, p53 shuttled from p53/-MDM2/-MEFs to ARF-overexpressing Saos-2 cells in majority of the heterokaryons examined. In a separate experiment, p53 was expressed in one set of p53'-MDM2/' Yue Xiong, Ph.D. MEFs, and then fused with another set of p53/--MDM2--MEFs that had been infected with Ad-hARF and identified by an antibody specifically recognizing human, but not mouse, ARF. In a majority (84%) of the heterokaryons formed by fusion of ARF-negative (Ad-p53 infected) and ARF-positive (uninfected) p53-'-MDM2/ MEFs, active p53 nuclear export was clearly observed. The efficiency of p53 nuclear-cytoplasmic shuttling between two murine nuclei through the murine cytoplasm is comparable to that seen between human and mouse nuclei through a mixed human/mouse cytoplasm. Thus, p53 nuclear export was not dependent on the presence of MDM2, and impaired p53 nuclear export by the L14Q/F19S and L22Q/W23S mutations is likely to be caused by a mechanism other than the disruption of p53-MDM2 association.
The p53 N-terminus contains a functional NES The NH 2 -terminal region of p53 contains two hydrophobic, leucine-rich stretches which resemble the CRM1-dependent NESes found in several different proteins including MDM2 and p53. The first leucine-rich stretch is highly conserved between human and mouse p53 (15 out 17 residues identical) while only 8 out of 18 residues in the second leucine-rich sequence are conserved. Notably, the L14Q/F19S and L22Q/W23S mutations each alter a highly conserved hydrophobic Leu residue shown to be critically important for NES function in cAMP-dependent protein kinase inhibitor, PKI, HDM2, and p53. We attached both p53'1 27 and p53 3 1 -47 peptides to GFP and determined whether these leucinerich motifs function as an autonomous NES. GFP distributes throughout both nucleus and cytosol, with slightly more accumulation in the nucleus. Fusion of GFP with the NES from either HDM2 or the p53 C-terminus (p 5 3 cNES) resulted in evident nuclear exclusion of fluorescence in about two-thirds of the cells, confirming the nuclear export activity of both NESes. Attachment of the peptide from p53 residues 11-27 (p 5 3 NES) to GFP generated clear nuclear exclusion of GFP in about two-thirds of the cells, a comparable efficiency with the NESes from HDM2 and the p53 C-terminus. The nuclear exclusion of GFP by fusion with all three NESes is, however, incomplete and nuclear fluorescence remains visible. This is likely due to the combination of weak NES activity, and visualization of cells as a plane, as opposed to three dimensionally, with the consequent inability to exclude cytoplasmic fluorescence surrounding the nucleus as non-nuclear signals. Fusion with the p53 3 1 -47 peptide only weakly affected GFP distribution and less than one-quarter of the GFP-positive cells exhibited a slight cytoplasmic accumulation of GFP. The significance of this weak nuclear export activity, if genuine, is difficult to assess and remains unclear at present. Inhibition of CRM1 by LMB treatment reverted the nuclear exclusion of GFP fused with HDM2NES, p 5 3 cNES, and p53nNES to that of GFP alone, indicating that nuclear export by these three NESes was CRM1-dependent. L14Q/F19S and L22QIW23S mutations prevented nuclear exclusion of p53nNES-GFP, reinforcing the functional importance of these hydrophobic residues and the authenticity of the p53 nNES. The nuclear export activity of the p 5 3 nNES, as well as that of the p 5 3 cNEs and the PKINES, was not detectably affected by the high level of ARF expression. Thus, the NH 2 -terminal domain of p53 appears to contain an autonomous NES that functions through the CRMl -dependent nuclear export pathway and is not dependent on MDM2.
DNA damage-induced phosphorylation at Ser-15 inhibits p53 nuclear export
The NH 2 -terminal p53 NES contains two serine residues, Ser" 5 and Ser 2°, adjacent to Leu1 4 and Leu 23 . Phosphorylation of both Ser" 5 and Ser 2° by several DNA-damage-activated p53 kinases has been linked to p53 stabilization and activation. To directly test the idea that phosphorylation at Ser1 5 and Ser 2° in p53 might impair the activity of the N-terminal NES, we determined nucleo-cytoplasmic shuttling of Yue Xiong, Ph.D.
DAMD 17-99-1-9574 phosphorylated p53 induced by DNA damage and fund that ectopically expressed Serl-phosphorylated p53 was inhibited from exporting. To determine whether endogenously expressed, Ser 1 5 -phosphorylated p53 is similarly blocked from export, U-20S cells were untreated or irradiated with UV and then fused with Saos-2 cells. Almost no p53 was detected in untreated U-20S cells. Upon UV irradiation, there was a substantial increase in total and Ser'-phosphorylated p53. Ser' 5 -phosphorylated p53 was localized mostly to speckles and exhibited a pattern distinct from that detected by the anti-full length p53 antibody, suggesting that phosphorylation of p53 is associated with or promotes a change of p53 subnuclear localization. While there was active p53 nuclear export as determined by the use of anti-full length p53 antibody, no Ser 15 -p53 signal was detected in the recipient Saos-2 cells (more than 30 heterokaryons examined). UV irradiation similarly resulted in a substantial increase in total and Ser 15 -phosphorylated p53 in MEFs. Consistently, Ser 15 -phosphorylated p53 was completely blocked from nuclear export.
REPORTABLE OUTCOMES Supported in part by the DAMD17-99-1-9574, we have discovered a novel regulation of tumor suppressor p53 that p53 contains a novel NES that is inhibited by DNA damage-induced phosphorylation. These results have resulted in a publication of a research paper in journal Science (Zhang and Xiong, 200 1a) and a review article in journal of Cell Growth & Differentiation ( Zhang and Xiong, 2001a) . A reprint of both papers is enclosed.
CONCLUSIONS
Our results reveal a previously unrecognized NES in the NH 2 -terminal region of p53 that is required for the nuclear export of p53. The two separate NESes of p53 can functionally collaborate with each other and synergistically mediate protein nuclear export. Having two separate NESes could provide cells with greater versatility in regulating p53 export. The COOH-terminal p53 NES is situated within the tetramerization domain, leading to the postulation that regulated p53 tetramerization occludes this NES, thereby ensuring nuclear retention of the active DNA-binding form of p53. The NH 2 -terminus of p53 contains several sites whose phosphorylation by various DNA-damage-activated p53 kinases lead to p53 stabilization and activation. Phosphorylation at Ser 15 and Ser 2° has been suggested to cause p53 stabilization by hindering p53-MDM2 binding. As p53 can undergo active nuclear export in the absence of MDM2, inhibition of MDM2 binding, while preventing p53 degradation, would not block p53 nuclear export and thus would not efficiently accumulate p53 in the nucleus to allow maximal p53 activation. On the other hand, inhibiting p53 nuclear export without breaking its binding with MDM2, although causing the nuclear accumulation of p53, would not reach maximal p53 activation either because MDM2, in addition to its activity in promoting cytoplasmic p53 degradation, can also directly inhibit p53's transactivating activity in the nucleus. We suggest that DNA damage-induced phosphorylation may achieve optimal p53 activation through the additive and complementary action of both inhibiting MDM2 binding to, and nuclear export of, p53. The p53 protein is present in low amounts in normally growing cells and is activated in response to physiological insults. MDM2 regulates p53 either through inhibiting p53's transactivating function in the nucleus or by targeting p53 degradation in the cytoplasm. We identified a previously unknown nuclear export signal (NES) in the amino terminus of p53, spanning residues 11 to 27 and containing two serine residues phosphorylated after DNA damage, which was required for p53 nuclear export in colloboration with the carboxy[-terminal NES. Serine-15-phosphory[ated p53 induced by ultraviolet irradiation was not exported. Thus, DNA damageinduced phosphorylation may achieve optimal p53 activation by inhibiting both MDM2 binding to, and the nuclear export of, p53.
The gene encoding p 5 3 mediates a major during normal cell growth by MDM2, a tumor suppression pathway that is frequently proto-oncogene discovered by its genomic altered in human cancers (1). p53 is inhibited amplification on a murine double minute chromosome, through either ubiquitin-dependent p53 degradation in the cytoplasm (2) leads to p53 stabilization and activation (8, domain, R273H (Arg 273 -His), which also positive nuclear export. Supporting the idea 9), and ARF stabilizes p53, iq part, by blockabolishes p53 transcriptional activity, had no that the inhibitory effect of the L22Q/W23S Pug the nuclear export of both p53 and detectable effect on p53 stability (18) . Demutation on p53 export may be reduced or MDM2 (10, 11) , underscoring the importance spite containing the intact NES in the COOHeven masked by the overproduction of p53, of nuclear export in regulating p53 stability, terminal region (14) , both p53L 14 Q/FI9s and endogenous p 53 Lz2Q/W23S protein produced The mechanism governing p53 nuclear p 5 3 L22Q/W23S exhibited substantially deby a knock-in strategy that was expressed at a export remains unclear, and three competing creased nuclear export activity, from 73% lower level is more completely blocked from models have been proposed (12). MDM2 with wild-type (WT) p53 to 23% and 15%, nuclear export and accumulates to very high may bind p53 in the nucleus and shuttle it to with the two mutants, respectively (Fig. 1 , levels in the nucleus [(19), Web fig. 1 (20) ], the cytoplasm (8, 13) , p53 may use a COOH-B and C). The transcriptionally inactive providing in vivo evidence for the disrupterminal-located nuclear export signal (NES) p53R 2 7 3 11 was exported at an efficiency indistion of p53 nuclear export by L22Q/W23S to mediate its own nuclear export (14) , or tinguishable from that of WT p53 (Fig. 1B) . mutations. MDM2 could ubiquitinate p53 in the nucleus Thus, the COOH-terminal-located NES was Blockage of p53 nuclear export by the to promote its nuclear export (15, 16) . To required, but was not sufficient, for p53 nu-L14Q/F19S and the L22Q/W23S mutations clarify the role of MDM2 in p53 nuclear clear export. This result is different from a could be attributed to the disruption of p53-export and discriminate between these modprevious report of normal nuclear export MDM2 association if MDM2 shuttled p53 els, we first examined the sensitivity to of a p53L 22 Q/w 23 s-green fluorescent protein out of the nucleus (10) or if MDM2 was MDM2-mediated degradation and nuclear (GFP) fusion (14) . Several experimental dif-required for p53 nuclear ubiquitination and export of p53 harboring either L14Q/FI9S ferences in that study could have contributed its subsequent export (15, 16) . Alternatively, (Leu 14 --GIn; Phe' 9 -> Ser) or L22Q/W23S to the discrepancy. These include the followit could be attributed to an intrinsic property (Leu 22 --Gln; Trp 23 -Ser) mutations (17) . ing, a four times longer cell fusion period, of the N11-terminal domain of p53. We carConsistent with previous reports (2), both which would result in prolonged protein exried out a series of heterokaryon assays to p5 3 Ln4Q/F]9S and p53L22Q/W 2 3 S were resisport; the electroporation of 10 times more determine if p53 nuclear export was depentant to degradation by HDM2 (human hoplasmid DNA, which would result in a higher dent on MDM2. After examining a large molog of MDM2) (Fig. IA) . The inhibition level of p53 protein; and the attachment of number of heterokaryons, we did not observe of HDM2-mediated p53 degradation by these a GFP moiety that might have increased cyapparent differences in p53 nuclear export mutations could not be attributed to the loss toplasmic retention of p53L22Q/w23s-GFP, efficiency in the absence of HDM2 or in the of p53 transcriptional activity, because a mu- 
-'--possibility that p53 nuclear export may be two-thirds of the cells, an efficiency compa-MDM2-/-MEFs were first infected with affected by the function of MDM2. rable with that of NESs from HDM2 and the p53-expressing adenoviruses and then fused
The NH 2 -terminal region of p53 contains p53 COOH-terminus. The nuclear exclusion with Saos-2 cells that had been infected with two hydrophobic, leucine-rich stretches that of GFP by fusion with all three NESs is, ARF-expressing adenoviruses to block resemble the chromosomal region maintehowever, incomplete, and nuclear fluores-MDM2 export (10, 11) . In these experiments, nance 1 (CRM1)-dependent NESs found in cence remains visible. This is probably due to p53 shuttled from p53-'--MDM2--MEFs several different proteins including MDM2 the combination of weak NES activity [see to ARF-overexpressing Saos-2 cells in a maand p53 (Fig. 3A) . The first leucine-rich Web fig. 3 for quantitative comparison (20)] jority (76%) of the heterokaryons examined stretch is highly conserved between human and visualization of cells as a plane, as op- (Fig. 2, A and C) . In a separate experiment, and mouse p53 (15 out of 17 residues are posed to three-dimensionally, with the conp53 was expressed in one set of p53---identical) whereas only 8 out of 18 residues sequent inability to exclude cytoplasmic flu-MDM2-'-MEFs, and then fused with anin the second leucine-rich sequence are conorescence surrounding the nucleus as nonother set of p53-/--MDM2-/-MEFs that served. Notably, the L14Q/Fl9S and L22Q/ nuclear signals. Fusion with the p 5 33 1 - 4 7 had been infected with adenovirus expressing W23S mutations each alter a highly conpeptide only weakly affected GFP distribuhARF (Ad-hARF) and identified by an antiserved hydrophobic Leu residue shown to be tion, and less than one-quarter of the GFPbody specific to human, but not mouse, ARF.
critically important for NES function in cyclic positive cells exhibited a slight cytoplasmic In a majority (84%) of the heterokaryons adenosine 3', 5'-monophosphate (cAMP)-accumulation of GFP. The significance of formed by fusion of ARF-negative (Ad-p53 dependent protein kinase inhibitor (PKI) (21), this weak nuclear export activity, if genuine, infected) and ARF-positive (uninfected)
HDM2 (8), and p53 (14) . We attached both is difficult to assess and remains unclear at p53-'--MDM2-/-MEFs, active p53 nuclep53 (Fig. 2, B and C) . The determined whether these leucine-rich motifs treatment reverted the nuclear exclusion of efficiency of p53 nuclear-cytoplasmic shutfunction as an autonomous NES. GFP distrib-GFP fused with HDM2NES, p 53 cNEs, and tling between two murine nuclei through the utes throughout both the nucleus and the p53nNEs to that of GFP alone (Fig. 3 , B and murine cytoplasm is comparable to that seen cytosol, with slightly more accumulation in C), indicating that nuclear export by these between human and mouse nuclei through a the nucleus (Fig. 3 , B and C). Fusion of GFP three NESs was CRMl-dependent. L14Q/ mixed human/mouse cytoplasm. Thus, p53
with the NES from either HDM2 or the p53 FI9S and L22Q/W23S mutations prevented nuclear export was not dependent on the pres-COOH-terminus (p53cNEs) resulted in evinuclear exclusion of p53nNES-GFP, reinforcence of MDM2, and impaired p53 nuclear dent nuclear exclusion of fluorescence in ing the functional importance of these hydroexport by the L14Q/F19S and L22Q/W23S about two-thirds of the cells (Fig. 3 , B and C), phobic residues and the authenticity of the p53 nNES. The nuclear export activity of the not cause any appreciable change in the nuphosphorylated p53 was determined by using p53nNi"S,, as well as that of tae p53cN s and clear and cytoplasmic distribution of fused either a goat antibody against full-length huthe PKINIYS, was not detectably affected by GFP. However, the substitution of both Ser 5 man p53 (anti-full-length p53) or a rabbit the high level of ARF expression (Fig. 3D) .
and Ser 2° with aspartic acid residues, which antibody raised against a synthetic phosphoThus, the NH 2 -terminal domain of p53 apoften mimic the charge of a phosphorylated Ser 5 p53 peptide (Fig. 4B) . Anti-full-length pears to contain an autonomous NES that serine, decreased nuclear export activity, as p53 antibody detected high levels of p53 in functions through the CRM1-dependent nujudged by the lack of visible nuclear exclualmost all U-20S cells (ARF negative) and clear export pathway and is not dependent on sion of fused GFP and an increase in the ratio lower amounts in the Saos-2 cells (ARF pos-MDM2.
of nuclear to cytoplasmic fluorescence (Fig.  itive) 
